2024年9月, 两场全球级肿瘤学术大会——2024年世界肺癌大会(WCLC)、欧洲肿瘤内科学会(ESMO)先后召开。透视这两场大会,阿斯利康第三代EGFR抑制 ...
who presented the data at the World Conference on Lung cancer (WCLC). Dato-DXd is heading for a decision in December from the FDA based on the Tropion-Lung01 data, with the jury out on its ...
The phase 2 HERTHENA-Lung01 study, reported over the weekend at the 2023 World Conference on Lung Cancer (WCLC), showed that patritumab deruxtecan showed "clinically meaningful and durable ...